Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)-Reference-Cited by-同舟云学术

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Published:2016-04 Issue:10026 Volume:387 Page:1415-1426
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Barlesi Fabrice,Mazieres Julien,Merlio Jean-Philippe,Debieuvre Didier,Mosser Jean,Lena Hervé,Ouafik L'Houcine,Besse Benjamin,Rouquette Isabelle,Westeel Virginie,Escande Fabienne,Monnet Isabelle,Lemoine Antoinette,Veillon Rémi,Blons Hélène,Audigier-Valette Clarisse,Bringuier Pierre-Paul,Lamy Régine,Beau-Faller Michèle,Pujol Jean-Louis,Sabourin Jean-Christophe,Penault-Llorca Frédérique,Denis Marc G,Lantuejoul Sylvie,Morin Franck,Tran Quân,Missy Pascale,Langlais Alexandra,Milleron Bernard,Cadranel Jacques,Soria Jean-Charles,Zalcman Gérard

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

4. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

5. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

Cited by 755 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung cancer in patients who have never smoked — an emerging disease;Nature Reviews Clinical Oncology;2024-01-09

2. Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer;British Journal of Cancer;2024-01-04

3. Research Progress in Clinical Therapeutic Efficacy and Safety of HER2-Positive Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024

4. Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis;The Lancet Regional Health - Europe;2024-01

5. Histology and molecular testing;Lung Cancer;2024